Quantum Biopharma reported net income of -$0.00B for the quarter ended Jun 2026. This income statement covers 31 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating items | |||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||
| Selling, General & AdministrativeSG&A | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||
| Other Operating ExpensesOther Opex | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||||||
| Operating ExpensesOpex | 0.01B | -0.00B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.00B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||
| Operating IncomeOp. Inc | -0.01B | 0.00B | 0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||
| EBIT | -0.01B | 0.00B | 0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 135.00 | 667.00 | -380.00 | 12.00 | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | ||||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | 0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | 0.00B | 0.00B | |||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | 74.00 | -0.00B | 0.00B | 0.01B | 0.00B | -0.00B | 0.01B | 0.00B | ||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.00B | 380.00 | -0.00B | ||||||||||||||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||
| EBT | -0.01B | 0.00B | 0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -1544.77B | 0.00B | -0.00B | -544.40B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||
| Profit After TaxPAT | -0.01B | 0.01B | 0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | -0.00B | -0.00B | -0.01B | -0.00B | |||||||||||
| Investment IncomeInv. Income | -0.00B | 0.00B | |||||||||||||||||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | -0.02B | 0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | 0.00B | |||||||||||
| Income from Continuing OperationsIncome (Continuing) | -0.01B | 0.00B | 0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -1544.77B | 0.00B | -0.00B | -544.40B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||
| Income from Discontinued OperationsIncome (Discontinued) | -0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | |||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -0.01B | 0.00B | 0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -1544.77B | 0.00B | -0.00B | -544.40B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | ||||||||||||
| Income towards Parent CompanyParent Net Inc | -0.01B | 0.00B | 0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | ||||||||||||
| Net Income towards Common StockholdersNet Income | -0.01B | 0.00B | 0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | ||||||||||||
| Additional items | |||||||||||||||||||||||||||||||
| EPS (Basic) | -0.44 | 0.04 | 0.15 | -0.12 | -0.20 | -0.17 | -0.25 | -0.09 | -0.03 | 0.16 | -0.08 | -0.13 | -1.84 | -3.01 | -4.37 | -4.20 | -0.70 | -0.91 | -0.72 | ||||||||||||
| EPS (Diluted) | -0.44 | 0.04 | 0.15 | -0.12 | -0.20 | -0.17 | -0.25 | -0.09 | -0.03 | 0.12 | -0.06 | -0.10 | -1.84 | -3.01 | -4.37 | -4.20 | -0.70 | -0.91 | -0.72 | ||||||||||||
| Shares Outstanding | 0.01B | 0.03B | 0.03B | 0.03B | 0.03B | 0.04B | 0.04B | 0.04B | 0.04B | 0.03B | 0.03B | 0.03B | 0.03B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.01B | 0.03B | 0.03B | 0.03B | 0.03B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.03B | 0.04B | 0.03B | 0.00B | 0.00B | ||||||||||||||||||||||||||
| EBITDA | -0.01B | 0.00B | 0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||||||||||||
| Interest ExpensesInt Expense | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 135.00 | 667.00 | -380.00 | 12.00 | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B |